,

Hemp Quotes

Quotes tagged as "hemp" Showing 1-30 of 103
“We are all unique, and for this reason, I teach about ECS Balance Control. Everyone can be different; we all have much to learn about our precious Endocannabinoid System that controls our body, future, and life.”
Mike Robinson, Founder Global Cannabinoid Research Center

“There's evidence that CBGa can influence fat metabolism, offering potential pathways for treating obesity and diabetes. Metabolic disorders are involved in every aspect of aging and we're finding cannabinoids will help us.”
Mike Robinson, Founder Global Cannabinoid Research Center

“As a cannabinoid researcher and advocate with a profound understanding of the endocannabinoid system (ECS), I recognize the limitations of relying solely on THC, including the risk of tolerance and potential side effects.”
Mike Robinson, Founder Global Cannabinoid Research Center

“We're learning that the Endocannabinoid system craves healthy foods to create more neurotransmitters that run our body and how our diet and lifestyle have as big of an impact on us as the use of the Cannabis plant or its extracts.”
Mike Robinson, Founder Global Cannabinoid Research Center

“Sleep deprivation increased circulating endocannabinoid levels by 33% in a study, which is a very unhealthy spike in upregulation; the same study found that people who were deprived also craved unhealthy foods.”
Mike Robinson, Founder Global Cannabinoid Research Center

“Exercise leads to both the production and release of endocannabinoids, which have the vast potential to restore one's energy reserves and offer analgesic and mood-enhancing benefits for the population in need of this.”
Mike Robinson, Founder Global Cannabinoid Research Center

“Patients do well using THC, but I suggest it more so at night to promote sleep and in the day if they have severe pain; the vast majority of people who go out looking for RSO have no tolerance at all for it and can't use much.”
Mike Robinson, Founder Global Cannabinoid Research Center

“The concentration of certain endocannabinoids, like 2-arachidonoylglycerol, follows a circadian rhythm and is disturbed by disrupted sleep patterns, causing its metabolism into 1 and 3 AG to occur too quickly. We need sleep.”
Mike Robinson, Founder Global Cannabinoid Research Center

“The biggest issue most have, even the seasoned veteran stoner, is the knowledge of which plant constituents will help them enjoy the numerous benefits and effects of THC.”
Mike Robinson, Founder Global Cannabinoid Research Center

“When we inhale high-THC cannabis, research already demonstrates how 2-AG production diminishes, quickly showing us why smoking a joint before bed can sometimes keep us up thinking about the meaning of life - or Netflix Binging.”
Mike Robinson, Founder Global Cannabinoid Research Center

“When our Endocannabinoid System balance is off it's either giving the body too much of one of the many endocannabinoids we have or too little, which can cause increased pain signaling and that causes a higher level of physical suffering.”
Mike Robinson, Founder Global Cannabinoid Research Center

“As much as THC is a powerful plant constituent I love so much, it's not as powerful as a finely tuned Endocannabinoid System; educating people to learn how to gain that ECS power by using cannabinoids is my mission.”
Mike Robinson, Founder Global Cannabinoid Research Center

“When the ECS is balanced, it gains a healthy tone. As this happens, the endocannabinoid Anandamide populates the system and naturally does the job many use THC for, this allows that cannabinoid to be enjoyed far more by lowering tolerance.”
Mike Robinson, Founder Global Cannabinoid Research Center

“The endocannabinoid system does not simply need plant cannabinoids to be healthy - it requires people to eat healthy foods, get sun, and exercise - we must break a sweat.”
Mike Robinson, Founder Global Cannabinoid Research Center

“We stand at the crossroads of history and science with Cannabis's journey from an ancient remedy to prohibition and now a modern therapeutic tool. Pioneers from the legacy world, not doctors and scientists, guide us along the way.”
Mike Robinson, Founder Global Cannabinoid Research Center

“Research implies a potential connection between poor endocannabinoid levels and many conditions we all want to avoid with scary names - giving us a good reason to learn about the Endocannabinoid System and harness the knowledge.”
Mike Robinson, Founder Global Cannabinoid Research Center

“During a lengthy cancer battle that included the use of large amounts of RSO or Cannabis oils with THC, the dose increased and increased - it got to the point that ingestion of 2 grams of 80% THC at once wasn't a problem - my ECS was out of balance.”
Mike Robinson, Founder Global Cannabinoid Research Center

“Many G-coupled protein receptors are responsible for modulating cannabinoids from the plant, and our body has yet to be considered part of the Endocannabinoid System (ECS). Our lifestyle often determines how healthy these receptors are.”
Mike Robinson, Founder Global Cannabinoid Research Center

“We are all unique, so I teach about Endocannabinoid System (ECS) Balance Control. It can be different for each person; knowing this and determining the tone of the individual is the only way to create the correct protocol for them.”
Mike Robinson, Founder Global Cannabinoid Research Center

“CBGa has shown promise and potential in reducing inflammation, a critical factor in many chronic diseases, and may protect nerve cells from damage, offering potential benefits for neurodegenerative diseases.”
Mike Robinson, Founder Global Cannabinoid Research Center

“When stressed, we start chewing into the Endocannabinoid Tone, and the balance becomes essential. We need to feel happy, and when we're stressed out the bliss molecule Anandamide runs low.”
Mike Robinson, Founder Global Cannabinoid Research Center

“The Potential to be used as biomarkers in blood tests to detect human disease is one of the most significant advances in the discovery of Endocannabinoids - including Cancers; researchers have already found that this can be an indicator of malignancies.”
Mike Robinson, Founder Global Cannabinoid Research Center

“GPR119, while not traditionally classified as an endocannabinoid receptor because it's not like CB1 and CB2, is responsive to specific lipid-based signaling molecules like OEA and a few others; some can be considered part of the broader Endocannabinoid system (ECS).”
Mike Robinson, Founder Global Cannabinoid Research Center

“The ECS doesn't need to produce what it already has, so if THC lands on receptors continuously, the body doesn't think it needs to produce the endocannabinoid Anandamide as they work alike: Tolerance and Balance become issues.”
Mike Robinson, Founder Global Cannabinoid Research Center

“GPR119 agonists like endocannabinoid OEA primarily stimulate insulin secretion when glucose levels are elevated in research, creating a target for type 2 diabetes therapies to enhance insulin secretion without risking hypoglycemia.”
Mike Robinson, Founder Global Cannabinoid Research Center

“In research, CBGa has actions much like a referee between cannabinoids from the plant and cannabinoids in the body, allowing for a healthy outcome either for those who use cannabis or have a downregulated ECS.”
Mike Robinson, Founder Global Cannabinoid Research Center

“THC on it's own doesn't always help our mental health during a crisis period - it can and does increase my own depression in the morning so I'm careful and make sure I wake and get CBGa, CBG, and CBD in my system immediately”
Mike Robinson, Founder Global Cannabinoid Research Center

“While CBGa does not bind directly to CB1 and CB2 receptors with high affinity, its influence on the synthesis of other cannabinoids that do, such as THC and CBD, can indirectly affect receptor activation and ECS function.”
Mike Robinson, Founder Global Cannabinoid Research Center

“A recent double-blinded randomized controlled trial of CBD found it had a beneficial impact on positive psychotic symptoms and severity of illness when delivered as an additional treatment to existing antipsychotic treatment.”
Mike Robinson, Founder Global Cannabinoid Research Center

“The patient will always tell you what works best if they're supplied and have access to Cannabinoids; many want to create a universal way to dose everyone - but we're all unique and respond differently to all substances, including plants.”
Mike Robinson, Founder Global Cannabinoid Research Center

« previous 1 3 4